Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Concert Pharmaceutic (NQ: CNCE )

3.660 USD -0.050 (-1.35%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 20, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 123,838
Open 3.612
Bid (Size) 3.500 (2)
Ask (Size) 3.660 (4)
Prev. Close 3.710
Today's Range 3.475 - 3.750
52wk Range 3.120 - 13.50
Shares Outstanding 32,173,778
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Concert Pharmaceuticals to Present at Upcoming Investor Conferences
In September, Concert will present virtually at the HC Wainwright and Cantor healthcare conferences. 
From Business Wire News Releases
Landmarks and Bridges Will Illuminate Blue Throughout the Month of September for Alopecia Areata Awareness Month
Landmarks across the USA will light it up blue for alopecia areata awareness month, which is recognized annually during September. 
From Business Wire News Releases

Performance

YTD
-71.16%
-71.16%
1 Month
+9.25%
+9.25%
3 Month
-12.44%
-12.44%
6 Month
-39.20%
-39.20%
1 Year
-64.29%
-64.29%

More News

Read More
Concert Pharmaceuticals Reports Second Quarter 2021 Financial Results
From Business Wire News Releases
Concert Pharmaceuticals to Report Second Quarter 2021 Results on August 5, 2021
From Business Wire News Releases
Looking into Concert Pharmaceuticals's Return on Capital Employed
Tags Benzinga BZI/ROCE Earnings
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Tags NARI CLPT Market News
From Benzinga
Concert Pharmaceuticals Presents Update on CTP-543 Long-Term Extension Study in Alopecia Areata During 2nd JAK Inhibitors Drug Development Summit
From Business Wire News Releases
Concert Pharmaceuticals, inc (CNCE) Q2 2021 Earnings Call Transcript
Tags CNCE Market News
From Motley Fool
Analysts Expect 10% Upside For VHT
Tags ETFs
From ETF Channel
Concert Pharma Sees US Application Submission For Patchy Hair Loss Candidate In 2023
Tags CNCE Biotech Benzinga
From Benzinga
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
Tags RDHL PRCT IBB
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.